SAFETY, TOLERABILITY AND PHARMACOKINETIC OF GIC-1001 FOLLOWING MULTIPLE ASCENDING DOSES ADMINISTRATIONS THROUGH AN ADAPTIVE FIRST IN HUMAN STUDY IN HEALTHY VOLUNTEERS.

被引：0
|
作者：
Paquette, J. M. [1 ]
Rufiange, M. [1 ]
Sadoune, A. Ait [1 ]
Sicard, E. [1 ]
Massicotte, J. [1 ]
Lefebvre, M. [1 ]
Colin, P. [2 ]
Ranger, M. [2 ]
机构：
[1] Algorithme Pharma, Laval, PQ, Canada
[2] gIcare Pharma Inc, Montreal, PQ, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S61 / S61
页数：1
相关论文
共 50 条
  • [21] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF RG1678. A NOVEL GLYCINE REUPTAKE INHIBITOR: A SINGLE ASCENDING DOSE STUDY IN HEALTHY VOLUNTEERS.
    Martin-Facklam, M.
    Hofmann, C.
    Banken, L.
    Alberati, D.
    Schmitt, G.
    Parrott, N.
    Hainzl, D.
    Robson, R.
    Nave, S.
    Boutouyrie, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S57 - S57
  • [22] Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.
    Abd-Elaziz, Khalid
    Kamphuisen, Pieter W.
    Lyssens, Christophe
    Reuvers, Mariska
    den Daas, Izaak
    Van Bockstaele, Femke
    Vercruysse, Kristof
    Ulrichts, Hans
    Baumeister, Judith
    Crabbe, Patricia
    Compernolle, Veerle
    Holz, Josefin-Beate
    BLOOD, 2009, 114 (22) : 439 - 440
  • [23] Safety, tolerability, and pharmacokinetics of single and multiple ascending Oral doses of DA-8010 in healthy subjects: First-in-human phase I study
    Lee, Dae Young
    Lee, Min Jung
    Ryu, Chaelim
    Lee, Heewon
    Brooks, Ashley
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (01):
  • [24] PHARM ACOKINETICS, PHARMACODYNAMICS, SAFETY, AND TOLERABILITY OF CEDIROGANT FOLLOWING SINGLE AND MULTIPLE DOSES IN JAPANESE AND CHINESE HEALTHY VOLUNTEERS
    Mohamed, M.
    Qian, Y.
    D'Cunha, R.
    Hao, S.
    De Prati, R. Carcereri
    Levy, G.
    Liu, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S42 - S42
  • [25] Pharmacokinetics, tolerability, and safety of pirfenidone (PFD), an antifibrotic agent, following single and multiple oral doses in healthy volunteers
    Shi, Shaojun
    Wu, Jianhong
    Chen, Huating
    Chen, Hui
    Wu, Jun
    Zeng, Fandian
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 197 - 197
  • [26] A First-in-Human Safety, Tolerability, and Pharmacokinetics Study of Benapenem in Healthy Chinese Volunteers
    Zhao, Cai-Yun
    Lv, Yuan
    Zhu, Yan
    Wei, Min-Ji
    Liu, Meng-Ying
    Ji, Xi-Wei
    Kang, Zi-Sheng
    Xia, Ya-Hong
    Tian, Ji-Hong
    Ma, Yan
    Liu, Yan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)
  • [27] SAFETY, AND TOLERABILITY OF NIM811, A NOVEL CYCLOPHILIN INHIBITOR FOR HCV, FOLLOWING SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY VOLUNTEERS AND HCV-INFECTED PATIENTS
    Ke, J.
    Lawitz, E.
    Rozier, R.
    Marbury, T.
    Nguyen, N.
    Serra, D.
    Dole, K.
    Praestgaard, J.
    Huang, M.
    Evans, T.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S229 - S229
  • [28] Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses
    Shue, Y. K.
    Sears, P. S.
    Shangle, S.
    Walsh, R. B.
    Lee, C.
    Gorbach, S. L.
    Okumu, F.
    Preston, R. A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) : 1391 - 1395
  • [29] Dose-Ascending, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of a Novel Long-Acting Recombinant Growth Hormone in Healthy Volunteers.
    Beckert, M.
    Geoffroy, P.
    Tayab, Z.
    Gilfoyle, D.
    Sprogoe, K.
    Nissen, T. Straight
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [30] Safety and tolerability of a single dose T0001 in Chinese healthy adult volunteers: a first-in-human ascending dose study
    Zhang, Tan
    Zhang, Minjie
    Zu, Li'an
    Wang, Qian
    Wang, Qi
    Wang, Wei
    Wang, Yitong
    Zang, Yannan
    Xie, Zhenwei
    Chen, Shi
    Wang, Mei
    Zheng, Qingshan
    Li, Zhanguo
    Chen, Guihong
    Fang, Yi
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 56 : 1 - 8
12345